Paper36978698
Three-Dimensional Printing of Poly-L-Lactic Acid Composite Scaffolds with Enhanced Bioactivity and Controllable Zn Ion Release Capability by Coupling with Carbon-ZnO.
Yuan X and 4 others. Bioengineering (Basel), 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Three-Dimensional Printing of Poly-L-Lactic Acid Composite Scaffolds with Enhanced Bioactivity and Controllable Zn Ion Release Capability by Coupling with Carbon-ZnO. Papers, record 36978698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Three-Dimensional Printing of Poly-L-Lactic Acid Composite Scaffolds with Enhanced Bioactivity and Controllable Zn Ion Release Capability by Coupling with Carbon-ZnO.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 52075158 | National Natural Science Foundation of China | PubMed | ||
| 52205355 | National Natural Science Foundation of China | PubMed | ||
| 2021JJ30109 | Natural Science Foundation of Hunan Province | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27426411 | Polylactic acid (PLA) controlled delivery carriers for biomedical applications. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/27426411 | PubMed |
| 2 | 28142232 | Enhanced Microwave Absorption Properties by Tuning Cation Deficiency of Perovskite Oxides of Two-Dimensional LaFeO3/C Composite in X-Band. | ACS Appl Mater Interfaces | 2017 | https://conductscience.org/library/papers/28142232 | PubMed |
| 3 | 28927621 | In vitro degradation and possible hydrolytic mechanism of PHBV nanocomposites by incorporating cellulose nanocrystal-ZnO nanohybrids. | Carbohydr Polym | 2017 | https://conductscience.org/library/papers/28927621 | PubMed |
| 4 | 34953261 | MOF-derived N-doped ZnO carbon skeleton@hierarchical Bi2MoO6 S-scheme heterojunction for photodegradation of SMX: Mechanism, pathways and DFT calculation. | J Hazard Mater | 2022 | https://conductscience.org/library/papers/34953261 | PubMed |
| 5 | 34901539 | Zn/Sr dual ions-collagen co-assembly hydroxyapatite enhances bone regeneration through procedural osteo-immunomodulation and osteogenesis. | Bioact Mater | 2022 | https://conductscience.org/library/papers/34901539 | PubMed |
| 6 | 36610365 | Novel coatings for the continuous repair of human bone defects. | Colloids Surf B Biointerfaces | 2023 | https://conductscience.org/library/papers/36610365 | PubMed |
| 7 | 33657451 | Natural medicine delivery from biomedical devices to treat bone disorders: A review. | Acta Biomater | 2021 | https://conductscience.org/library/papers/33657451 | PubMed |
| 8 | 34033149 | Emerging of Heterostructure Materials in Energy Storage: A Review. | Adv Mater | 2021 | https://conductscience.org/library/papers/34033149 | PubMed |
| 9 | 33718692 | Bone tissue engineering techniques, advances and scaffolds for treatment of bone defects. | Curr Opin Biomed Eng | 2021 | https://conductscience.org/library/papers/33718692 | PubMed |
| 10 | 31725272 | An Asymmetric Supercapacitor Based on a Non-Calcined 3D Pillared Cobalt(II) Metal-Organic Framework with Long Cyclic Stability. | Inorg Chem | 2019 | https://conductscience.org/library/papers/31725272 | PubMed |
| 11 | 27094868 | Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys. | Adv Healthc Mater | 2016 | https://conductscience.org/library/papers/27094868 | PubMed |
| 12 | 32427264 | Zinc oxide nanoparticles for therapeutic purposes in cancer medicine. | J Mater Chem B | 2020 | https://conductscience.org/library/papers/32427264 | PubMed |
| 13 | 33024903 | Recent research and progress of biodegradable zinc alloys and composites for biomedical applications: Biomechanical and biocorrosion perspectives. | Bioact Mater | 2021 | https://conductscience.org/library/papers/33024903 | PubMed |
| 14 | 33997435 | 3D Printed Zn-doped Mesoporous Silica-incorporated Poly-L-lactic Acid Scaffolds for Bone Repair. | Int J Bioprint | 2021 | https://conductscience.org/library/papers/33997435 | PubMed |
| 15 | 21999213 | New approach to bone tissue engineering: simultaneous application of hydroxyapatite and bioactive glass coated on a poly(L-lactic acid) scaffold. | ACS Appl Mater Interfaces | 2011 | https://conductscience.org/library/papers/21999213 | PubMed |
| 16 | 32123774 | Design biodegradable Zn alloys: Second phases and their significant influences on alloy properties. | Bioact Mater | 2020 | https://conductscience.org/library/papers/32123774 | PubMed |
| 17 | 30480879 | 3D Microfibrous Scaffolds Selectively Promotes Proliferation and Glial Differentiation of Adult Neural Stem Cells: A Platform to Tune Cellular Behavior in Neural Tissue Engineering. | Macromol Biosci | 2019 | https://conductscience.org/library/papers/30480879 | PubMed |
| 18 | 31351253 | Current status and perspectives of zinc-based absorbable alloys for biomedical applications. | Acta Biomater | 2019 | https://conductscience.org/library/papers/31351253 | PubMed |
| 19 | 28613076 | Metal-Organic Framework-Derived Nanoporous Metal Oxides toward Supercapacitor Applications: Progress and Prospects. | ACS Nano | 2017 | https://conductscience.org/library/papers/28613076 | PubMed |
| 20 | 30036727 | Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. | Biomaterials | 2018 | https://conductscience.org/library/papers/30036727 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42164596 | Microinjection molded PLA/ZnO-TiO2 composites with in situ fibrillation: achieving mechanical matching cortical bone and enhanced osteoinduction. | RSC Adv | 2026 | https://conductscience.org/library/papers/42164596 | PubMed |
| 41007161 | Analysis of Conventional and Enhanced-Biocompatibility ZnO/Ag Heterojunction Nanorod-Based Advanced Root Canal Sealers. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/41007161 | PubMed |
| 38017585 | Phototherapy techniques for the management of musculoskeletal disorders: strategies and recent advances. | Biomater Res | 2023 | https://conductscience.org/library/papers/38017585 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978698
GET https://conductscience.org/api/papers/v1/36978698/references?page=2